A feasible strategy based on isotopic fine structures to enhance the reliability of metabolite identification by FT-ICR MS.
In the process of identification of unknown metabolites, the most important thing is to determine their real chemical formulae according to the accurate mass which were detected by high-resolution mass spectrometry (HRMS). However, high mass accuracy alone is not enough to exclude false candidates. Use of isotopic fine structures (IFSs) derived from FT-ICR MS as a single further constraint could decisively determine the molecular formula for unknown metabolites. Gastrodin, an active constituent from Gastrodia elata Bl., which could penetrate through the blood-brain barrier and rapidly decompose to p-hydroxybenzyl alcohol in the brain, was selected as the model drug. The accurate mass, possible chemical formulae and IFSs of its metabolites in rat plasma were acquired by FT-ICR MS. Besides gastrodin, a total of eight metabolites including two phase I and six phase II metabolites were detected. Their chemical formulae were decisively determined by IFSs. Furthermore, their chemical structures were identified by comparing their fragment ions with those of gastrodin. Results indicated that metabolic pathways of gastrodin in rats including deglycosylation, oxidation, glucuronidation, sulfate conjugation and glycine conjugation. It demonstrated that IFSs were effective in unambiguous determination of chemical formulae of metabolite. It could be used as a feasible strategy to enhance the reliability of metabolite identification in drug metabolism studies.